Application 209139
- Type
- NDA
- Sponsor
- CARMEL BIOSCIENCES
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PREXXARTAN | VALSARTAN | SOLUTION;ORAL | 20MG/5ML | Yes | No |
| 002 | PREXXARTAN | VALSARTAN | SOLUTION;ORAL | 80MG/20ML | Yes | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N209139-001 | PREXXARTAN | VALSARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | AB | RLD | 2017-12-19 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N209139-001 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | AB | RLD | 2017-12-19 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | AB | RLD | 2017-12-19 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | AB | RLD | 2017-12-19 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N209139-001 | PREXXARTAN | 4MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N209139-001 | PREXXARTAN | 20MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N209139-002 | PREXXARTAN | 80MG/20ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | SOLUTION / ORAL | RLD | 2017-12-19 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | bb7c543d1eb4… | |
| 2022-03-09 01:35 UTC | 2022-03 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | N209139-001 | PREXXARTAN | 20MG/5ML | SOLUTION / ORAL | RLD | 2017-12-19 | 782e0a99824c… | |
| 2021-12-28 21:50 UTC | 2021-12 | N209139-002 | PREXXARTAN | 80MG/20ML | SOLUTION / ORAL | RLD | 2017-12-19 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N209139-001 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N209139-001 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N209139-001 | AB | 1 | caaa826d4ba7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Valsartan | VALSARTAN | Zydus Lifesciences Limited | 1b60c816-7399-42c3-8b74-4dc9d82873ec | 2024-07-23 | VALSARTAN | |
| Valsartan | VALSARTAN | Aurobindo Pharma Limited | a81a72dd-e828-4208-af9b-bb9ac4938537 | 2024-05-19 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Lupin Pharmaceuticals, Inc. | 9eb9d98e-7057-4ca0-91ab-2030bc0120a6 | 2024-03-22 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Bryant Ranch Prepack | d9a16816-d4de-401a-8413-7233f4e541f8 | 2024-01-16 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Amneal Pharmaceuticals of New York LLC | f13587f8-76cb-49ad-9291-5907249d6b8e | 2023-12-14 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Bryant Ranch Prepack | e8fcd4c2-8baa-452a-b723-5cb3d8d203a9 | 2023-12-14 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Bryant Ranch Prepack | 4e160647-a08e-40e8-b566-3e97a09c616a | 2023-11-22 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | A-S Medication Solutions | 688b5c82-2eba-445c-869e-60609f5db86a | 2023-10-03 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Bryant Ranch Prepack | bcbd44f6-d49a-4a59-bba5-70fb843d1f59 | 2023-09-25 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | ANI Pharmaceuticals, Inc. | 959b6790-feb7-45a9-9ea4-0ee1a7fce048 | 2023-09-18 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | SQUARE PHARMACEUTICALS LIMITED | 5ee97546-2a7c-40fa-9e05-b7993a72dfbf | 2023-07-02 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| valsartan | VALSARTAN | A-S Medication Solutions | 80987771-ccb4-4a9f-a395-0af4c2621e0a | 2023-02-04 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| valsartan | VALSARTAN | A-S Medication Solutions | e352db8b-0485-492a-8734-0a415566d764 | 2023-02-04 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| valsartan | VALSARTAN | A-S Medication Solutions | 9f5a400f-9cfc-4d25-a677-73cbb14375e2 | 2023-02-04 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | A-S Medication Solutions | 506ab3dd-c5eb-4755-ad10-bc116f4443c7 | 2023-01-31 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Alembic Pharmaceuticals Limited | 6e2cd953-88bf-4094-8ba8-2c9ba020f4d7 | 2023-01-12 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Proficient Rx LP | fadb25bb-acd9-4aaf-971c-82259b739e5b | 2022-11-01 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Lifsa Drugs LLC | 130e1659-9c2d-49ca-9db8-d28aa23fd133 | 2022-04-07 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Unichem Pharmaceuticals (USA), Inc. | 93b82a9f-dc0a-4f7d-b0d4-4adf0d917b7e | 2021-09-09 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
| Valsartan | VALSARTAN | Alembic Pharmaceuticals Inc. | 8478a05f-38fd-412d-af49-69a73a787c8f | 2021-08-18 | Boxed warning, Warnings, Adverse reactions | VALSARTAN |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 25208-100 | PREXXARTAN | PREXXARTAN | Medicure International Inc. | NDA | Current |